ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

42,820Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 247

$3.49M Total Retail Price of All Prescriptions

Rank: 1 out of 247

629 Patients Receiving at Least One Drug in Part D
90% Patients 65 Years and Older
99% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in California
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

23% of this provider’s 629 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Brand Name Drugs

39% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%. This is far more than peers.

Prescription Price

$81 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

68 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in California
ATORVASTATIN CALCIUM 2,390 2,176 326 1 6
METOPROLOL SUCCINATE 2,033 1,883 246 10 2 22
VALSARTAN-HYDROCHLOROTHIAZIDE 1,548 1,410 234 10 3 72
NEXIUM 1,386 1,282 183 4 39
CARVEDILOL 1,218 1,105 140 5 23
CRESTOR 1,196 1,103 153 6 46
AMLODIPINE BESYLATE 1,064 987 144 7 2
FENOFIBRATE* 998 890 151 8 63
DIOVAN 896 837 138 9 28
IBANDRONATE SODIUM 869 823 119 10 10 99
METFORMIN HCL 868 790 117 11 10
FUROSEMIDE 824 747 129 12 5
GLIMEPIRIDE 824 741 93 12 78
JANUMET 793 715 95 10 14 123
OMEPRAZOLE 709 645 113 15 4
LEVOTHYROXINE SODIUM 682 647 70 16 1
TAMSULOSIN HCL 629 615 87 17 20
BENICAR HCT 605 588 85 10 18 127
CLONIDINE 590 564 83 10 19 143
CELEBREX 586 519 111 20 58
LYRICA 575 516 86 21 81
SERTRALINE HCL 574 522 93 22 35
CLOPIDOGREL 568 509 68 23 21
CLONIDINE HCL 561 510 95 24 59
LIDODERM 511 455 99 25 48
ZOLPIDEM TARTRATE 489 464 89 26 26
DIOVAN HCT 476 459 130 10 27 158
MONTELUKAST SODIUM 467 441 79 28 53
ADVAIR DISKUS 466 440 84 29 45
ALENDRONATE SODIUM 391 386* 58 30 18
PANTOPRAZOLE SODIUM 369 311 68 31 24
CYMBALTA 363 295 52 32 44
VOLTAREN 358 326 83 33 97
IBUPROFEN 349 308 88 34 67
ACETAMINOPHEN-CODEINE 344 339* 102 S3 35 90
ISOSORBIDE MONONITRATE ER 334 322 47 36 56
VESICARE 328 277 50 37 133
LANTUS 313 286 48 38 43
DONEPEZIL HCL 311 311 49 39 15
LOSARTAN-HYDROCHLOROTHIAZIDE 311 273 51 39 76
MELOXICAM 297 271 63 41 52
HYDROCODONE-ACETAMINOPHEN 291 235 50 S3 42 8
ALPRAZOLAM 289 263 55 B 43 51
METOPROLOL TARTRATE 279 274* 45 44 11
SIMVASTATIN 275 258 38 45 3
NAMENDA 274 274 39 46 14
LORAZEPAM 269 246 52 B 47 25
JANUVIA 265 247 50 48 47
DICLOFENAC SODIUM 259 216 80 49 93
MECLIZINE HCL 257 252* 79 50 149
WARFARIN SODIUM 239 239 17 51 9
AVODART 225 220* 33 52 141
BACLOFEN 223 200 63 53 68
KETOCONAZOLE 218 197 106 54 161
SPIRIVA 215 201 31 55 73
PRAVASTATIN SODIUM 209 189 35 56 37
ZETIA 204 199* 31 57 112
ALCOHOL PREP PADS 201 196* 80 58 246
LOVAZA 194 182 37 59 111
TRAMADOL HCL 193 157 37 60 34
FAMOTIDINE* 185 172 38 61 30
FENOFIBRATE* 184 145 28 62 63
NITROGLYCERIN PATCH 182 177* 31 63 173
LEVOFLOXACIN 175 158 144 64 79
LANSOPRAZOLE 166 161* 30 65 151
KOMBIGLYZE XR 150 118 22 66 263
TRIAMCINOLONE ACETONIDE 143 138* 80 67 65
AMITIZA 141 127 29 68 196
HYDRALAZINE HCL 141 141 25 68 57
GABAPENTIN 139 97 22 70 12
DEXILANT 137 132* 22 71 121
HUMALOG 135 113 25 72 146
ALLOPURINOL 135 123 21 72 40
CLONAZEPAM 129 116 27 B 74 89
NOVOLOG 128 102 23 75 87
TEMAZEPAM 126 121* 32 B 76 85
ACTONEL 125 120* 24 77 169
ESCITALOPRAM OXALATE 119 94 17 78 41
AMIODARONE HCL 108 103* 17 79 137
FINASTERIDE 105 100* 16 80 66
LACTULOSE 100 95* 22 81 88
GLYBURIDE-METFORMIN HCL 98 93* 15 R 82 153
PRANDIN 94 94 18 83 249
SYMBICORT 85 74 13 84 236
COLCRYS 84 56 17 85 184
AZITHROMYCIN 84 79* 74 85 55
SPIRONOLACTONE 83 78* 14 87 82
COREG CR 83 69 26 87 312
XARELTO 83 83 15 87 164
INSULIN SYRINGE* 82 63 19 90 212
BENICAR 80 75* 17 91 129
DIGOX 80 80 15 91 60
NIASPAN 79 <11 <11 93 159
BYSTOLIC 77 72* 13 94 143
CIPROFLOXACIN HCL 76 71* 66 95 77
NASONEX 75 62 38 96 170
LEVEMIR 75 42 12 96 131
OXYBUTYNIN CHLORIDE ER 74 62 11 98 115
VASCEPA 72 67* 14 99 319
QUETIAPINE FUMARATE 71 66* 14 A 100 36
MICARDIS HCT 70 <11 <11 101 322
METHIMAZOLE 69 <11 <11 102 285
AGGRENOX 67 <11 <11 103 186
EXELON 67 67 12 103 91
WELCHOL 66 <11 <11 105 267
POLYETHYLENE GLYCOL 3350 66 66 12 105 80
SINGLE USE SWAB 61 56* 23 107 269
PIOGLITAZONE HCL 60 <11 <11 R 108 94
DICYCLOMINE HCL 59 54* 29 109 256
SURE COMFORT* 59 44 13 109 279
LOSARTAN POTASSIUM 58 46 14 111 13
PREDNISONE 57 52* 39 112 49
NYSTATIN 55 50* 33 113 124
METOCLOPRAMIDE HCL 55 50* 18 113 117
AMLODIPINE BESYLATE-BENAZEPRIL 50 <11 <11 115 128
MIRTAZAPINE 50 50 13 115 27
CREON 50 <11 <11 115 96
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.